KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Liabilities and Shareholders Equity (2016 - 2025)

Cme (CME) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $198.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 44.36% to $198.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $723.3 billion, a 36.3% increase, with the full-year FY2025 number at $198.4 billion, up 44.36% from a year prior.
  • Liabilities and Shareholders Equity was $198.4 billion for Q4 2025 at Cme, up from $187.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $205.9 billion in Q1 2022 to a low of $123.4 billion in Q2 2024.
  • A 5-year average of $164.2 billion and a median of $170.1 billion in 2022 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 57.85% in 2021, then fell 29.61% in 2023.
  • Cme's Liabilities and Shareholders Equity stood at $196.8 billion in 2021, then dropped by 11.49% to $174.2 billion in 2022, then dropped by 25.53% to $129.7 billion in 2023, then grew by 5.97% to $137.4 billion in 2024, then skyrocketed by 44.36% to $198.4 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Liabilities and Shareholders Equity are $198.4 billion (Q4 2025), $187.1 billion (Q3 2025), and $179.9 billion (Q2 2025).